88IV - PR Newswire Asia's news


TenNor Therapeutics Reports Positive Phase IIa POC Data for Rifaquizinone (TNP-2092), the First Non-Surgical Therapy Candidate for Periprosthetic Joint Infection — Phase IIb multicenter trial initiated, bringing this potential life-changing therapy closer to patients — ... 2026-09-10T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Nuritas Appoints Former Unilever North America President Kees Kruythoff as Board Chair The 30-year industry veteran brings global scaling and commercialization expertise to biotech leader Nuritas. ... 2026-09-10T Biotechnology Health Care/Hospital
/C O R R E C T I O N -- CordenPharma/ In the news release, CordenPharma Boosts Aseptic Fill-Finish Capacity to 500 Million Sterile Injectable Units Per Year, issued 10-Sep-2026 by CordenPharma over PR Newswire, we are advised by the company ... 2026-09-10T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
BGI Genomics Launches "Digital Life Twin" Framework to Power Proactive Health SHENZHEN, China , Sept. 9, 2026 /PRNewswire/ -- Commemorating BGI Group's 27th anniversary, BGI Genomics today introduced its Digital Life Twin framework alongside an advanced multi-omics diagnostic ... 2026-09-09T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Yuyu Pharma CEO Robert Wonsang Yu Launches "Robert's YUniverse" Podcast SEOUL, South Korea , Sept. 9, 2026 /PRNewswire/ -- Robert Wonsang Yu, CEO of Yuyu Pharma, has launched " Robert's YUniverse " , a new podcast series featuring conversations with guests ... 2026-09-09T Biotechnology Medical/Pharmaceuticals
First Participant Dosed in First-in-Human Phase 1 Study of GZC8072, a Novel Ultra-Long-Acting Once-Weekly Oral Peptide GLP-1 RA BEIJING and BRIDGEWATER, Mass. , Sept. 9, 2026 /PRNewswire/ -- Gan&Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan&Lee) announced that the first participant has been dosed in a ... 2026-09-09T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Moonwalk Biosciences Announces $70 Million Series B: NYSE Content Update NYSE issues a pre-market daily advisory direct from the trading floor. ... 2026-09-09T Banking/Financial Service Biotechnology
Full-Life Technologies Announces U.S. FDA IND Clearance and Australian Regulatory Clearance for [22⁵Ac]Ac-FL-261 Phase 1 Clinical Trial LONDON , Sept. 9, 2026 /PRNewswire/ -- Full-Life Technologies ("Full-Life", the "Company") , a privately held, fully integrated, clinical-stage actinium-based global radiopharmaceutical ... 2026-09-09T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Transcenta Therapeutics and WuXi Biologics Enter into Strategic Collaboration to Accelerate Commercialization of HiCB Continuous Bioprocessing Technologies PRINCETON, N.J. and SUZHOU, China , Sept. 9, 2026 /PRNewswire/ -- Transcenta Therapeutics (HKEX: 06628), a global clinical-stage biopharmaceutical company with fully integrated capabilities in discovery, ... 2026-09-09T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Daesang Targets Global Pharmaceutical Amino Acid Market, Building on 70 Years of Fermentation Technology Leverages fermentation know-how developed through MIWON to expand beyond general-purpose amino acids into high-value pharmaceutical materials Acquires Germany-based AMINO GmbH, gaining purification ... 2026-09-09T Biotechnology Food/Beverages Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology